BSE Live
Dec 10, 15:29Prev. Close
352.60
Open Price
358.10
Bid Price (Qty.)
340.90 (1)
Offer Price (Qty.)
345.65 (66)
NSE Live
Dec 10, 15:29Prev. Close
351.70
Open Price
351.25
Bid Price (Qty.)
340.55 (250)
Offer Price (Qty.)
343.00 (49)
| Key Financial Ratios of Gufic Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 6.97 | 8.74 | 8.22 | 9.89 | 4.56 | |
| Diluted EPS (Rs.) | 6.97 | 8.74 | 8.22 | 9.89 | 4.56 | |
| Cash EPS (Rs.) | 9.07 | 10.29 | 10.52 | 11.65 | 6.24 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 59.97 | 53.11 | 35.88 | 27.76 | 17.89 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 59.97 | 53.11 | 35.88 | 27.76 | 17.89 | |
| Dividend / Share(Rs.) | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | |
| Revenue from Operations/Share (Rs.) | 81.75 | 80.44 | 71.24 | 80.37 | 50.31 | |
| PBDIT/Share (Rs.) | 13.96 | 14.76 | 14.15 | 15.35 | 9.04 | |
| PBIT/Share (Rs.) | 11.86 | 13.07 | 11.86 | 13.58 | 7.36 | |
| PBT/Share (Rs.) | 9.42 | 11.54 | 11.01 | 13.08 | 5.95 | |
| Net Profit/Share (Rs.) | 6.97 | 8.59 | 8.22 | 9.89 | 4.56 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 17.07 | 18.35 | 19.86 | 19.10 | 17.97 | |
| PBIT Margin (%) | 14.50 | 16.24 | 16.64 | 16.90 | 14.62 | |
| PBT Margin (%) | 11.51 | 14.33 | 15.45 | 16.27 | 11.83 | |
| Net Profit Margin (%) | 8.53 | 10.67 | 11.54 | 12.30 | 9.06 | |
| Return on Networth / Equity (%) | 11.62 | 16.17 | 22.91 | 35.61 | 25.50 | |
| Return on Capital Employed (%) | 15.20 | 18.18 | 20.06 | 39.37 | 31.23 | |
| Return on Assets (%) | 5.97 | 7.88 | 9.25 | 18.38 | 11.28 | |
| Total Debt/Equity (X) | 0.52 | 0.60 | 0.90 | 0.23 | 0.30 | |
| Asset Turnover Ratio (%) | 0.72 | 0.83 | 1.00 | 1.71 | 124.39 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.61 | 1.61 | 1.61 | 1.72 | 1.59 | |
| Quick Ratio (X) | 1.05 | 1.08 | 0.97 | 1.10 | 1.02 | |
| Inventory Turnover Ratio (X) | 3.93 | 1.73 | 2.27 | 3.37 | 5.17 | |
| Dividend Payout Ratio (NP) (%) | 1.43 | 1.12 | 1.21 | 1.01 | 0.87 | |
| Dividend Payout Ratio (CP) (%) | 1.10 | 0.93 | 0.95 | 0.85 | 0.64 | |
| Earnings Retention Ratio (%) | 98.57 | 98.88 | 98.79 | 98.99 | 99.13 | |
| Cash Earnings Retention Ratio (%) | 98.90 | 99.07 | 99.05 | 99.15 | 99.36 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,656.02 | 3,142.93 | 2,074.20 | 2,447.63 | 1,146.65 | |
| EV/Net Operating Revenue (X) | 4.46 | 3.90 | 3.00 | 3.14 | 2.35 | |
| EV/EBITDA (X) | 26.11 | 21.23 | 15.12 | 16.45 | 13.08 | |
| MarketCap/Net Operating Revenue (X) | 4.12 | 3.52 | 2.62 | 3.10 | 2.27 | |
| Retention Ratios (%) | 98.56 | 98.87 | 98.78 | 98.98 | 99.12 | |
| Price/BV (X) | 5.61 | 5.33 | 5.20 | 8.97 | 6.39 | |
| Price/Net Operating Revenue | 4.12 | 3.52 | 2.62 | 3.10 | 2.27 | |
| Earnings Yield | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 |
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y